J. CHEM. RESEARCH (S), 1999 283
Alcohol 3a.öMajor diastereomer (80%): dH (300 MHz, CDCl3)
1.22 (d, 3 H, J 7 Hz), 1.45 (s, 9 H), 2.47 (d, 1 H, J 2:1 Hz), 3.55
(s large, 1 H), 3.75^4.05 (m, 1 H) 4.40 (dxd, 1 H, J 2:4 Hz,
J0 2:1 Hz), 4.77 (s large, 1 H). Minor diastereomer (20%): distinct
signals d 4.35 (dxd, 1 H, J 5:5 Hz, J0 2:1 Hz).
Boc
Boc
NH
N
O
H
H4
H3C
H5
H
i
S
R
Oxazoline Derivative 5.öOn the basis of the 1H NMR coupling
constant (5.4 Hz) and molecular modelling study using the program
SYBYL v. 5.1 (Tripos Associates, St Louis, MO) (torsion between
H4 and H5 298) we suggest for the main diastereomer a syn
stereochemistry and a 4S, 5R relative stereochemistry at C4 and
C5, assuming that the chiral centre of the UNCA was ¢xed. For
the minor diastereomer, the measured coupling constant (3.3 Hz)
and the torsion between H4 and H5 (1008) suggest an anti
stereochemistry.
H3C
OH
H
H
3a
5
Scheme 3
The relative con¢guration of 5 was assigned on the basis of
the 1H NMR coupling constant between H4 and H5. The
mixture of stereoisomers was quanti¢ed by the distinguish-
able signals.
The N-protected b-amino-a-hydroxyalkanoic acids 4 were
synthesized as shown in Scheme 1. Alcohols 3 were then
protected by tetrahydropyranylation in quantitative yields
before oxidative cleavage. Oxidation of these intermediates
into acids (norstatines) was achieved using the RuCl3/NaIO4
method10 in 58^65% yields.
Received, 2nd December 1998; Accepted, 4th January 1999
Paper E/8/09421G
References
1
H. Umezawa, T. Aayagi, H. Morishima, M. Matzuzaki, M.
Hamada and T. Takeuchi, J. Antibiot., 1970, 23, 259.
A. Willey and D. H. Rich, Med. Res. Rev., 1993, 13, 327.
ꢀa T. F. Tam, J. Carriere, D. McDonald, A. L. Castelhano, D.
H. Pliura, N. J. Dewdney, E. M. Thomas, C. Bach, J. Barnett,
H. Chan and A. Krantz, J. Med. Chem., 1992, 35, 1318; ꢀb N.
Shibata, E. Itoh and S. Terashima, Chem. Pharm. Bull., 1998,
46, 733.
In summary, we have demonstrated
a
convenient
2
3
diastereoselective synthesis of norstatines from UNCAs.
The procedure described in this paper allows the preparation
of (2S, 3S)-norstatines. The interest in this methodology is to
allow the preparation of both (2S, 3S)- and (2R, 3S)-
norstatines with the reducing agent used here.
4
5
6
K. Iizuka, T. Kamijo, T. Kubota, K. Akahane, H. Umeyama
and Y. Kiso, J. Med. Chem., 1988; 31, 702.
J. A. Fehrentz, J. C. Califano, M. Amblard, A. Lo¡et and J.
Martinez, Tetrahedron Lett., 1994, 35, 569.
J. A Fehrentz, E. Bourdel, J. C. Califano, O. Chaloin, C.
Devin, P. Garouste, A. C. Lima-Leite, M. Llinares, F.
Rieunier, J. Vizavonna, F. Winternitz, A. Lo¡et and J.
Martinez, Tetrahedron Lett., 1994, 35, 1557.
J. A. Fehrentz, C. Pothion, J. C. Califano, A. Lo¡et and J.
Martinez, Tetrahedron Lett., 1994, 35, 9031.
Experimental
The following procedure is representative. To a stirred solution of
ethynylmagnesium bromide in THF (6.0 mmol) was added under
nitrogen atmosphere at 60 8C, a solution of UNCA (5 mmol) in
THF (10 ml). The reaction mixture was stirred for 4 h between 60
and 40 8C and then quenched with NH4Cl (10 ml). The product was
extracted with ethyl acetate. The combined organic layers were dried
over Na2SO4 and concentrated in vacuo to give an oil which was
puri¢ed by chromatography on silica gel. The keto-acetylenic com-
pound 2a was obtained in 72% yield; mp 66^67 8C, [a]2D0 35:7 (c,
7
8
9
S. Kourtal and J. Paris, Lett. Peptide Sci., 1996, 3, 73.
A. L. Gemal and J. L. Luche, J. Am. Chem. Soc., 1981, 103,
5454.
1
1.0, methanol); n=cm (KBr) 3398, 3213, 2084, 1690, 1378, 1166;
dH (200 MHz, CDCl3) 1.42 (d, 3 H, J 7 Hz), 1.45 (s, 9 H), 3.37
10 P. H. Carlsen, T. Katsuki, V. S. Martin and K. B. Sharpless, J.
Org. Chem., 1981, 46, 3936.
(s, 1 H), 4.42 (qxd, 1 H, J J0 7 Hz), 5.12 (s large, 1 H).